Tiny tummies, happy bums: probiotic drops tested for diaper rash
NCT ID NCT06755307
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a daily probiotic supplement called OMNiBiOTiC® Panda can shorten the time babies under two years old have diaper rash. Forty-two children will receive either the probiotic or a placebo for three weeks, and parents will track rash symptoms daily. The goal is to see if the probiotic helps the rash clear up faster than the placebo.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- OMNiBiOTiC® Panda (a multistrain probiotic supplement)
- What this could lead to
- If it works, this could offer a simple, drug-free way to help babies recover from diaper rash faster.
- What could go wrong
- This is a small, early-stage trial with only 42 children. The probiotic may not shorten rash duration compared to placebo, and results may not apply to all babies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 42 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Aug 2025
- Expected to finish
-
Mar 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
1 month to 2 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * presence of diaper dermatitis * age less than two years Exclusion Criteria: * previous use of probiotics * age more than two years * an acute bacterial infection * chronic disease * local use of antibiotics in the anogenital region
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diaper dermatitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Maribor, Faculty of Health Sciences
RECRUITINGMaribor, 2000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breast milk vs. baby cream: which wins for diaper rash?
- Kitchen oils may shield babies from diaper rash
- Mushroom cream soothes baby skin rashes in new study
- Simple air therapy may protect NICU newborns from painful diaper rash
- Natural oils tested as gentle remedy for baby diaper rash
- New diaper rash treatment tested on tiniest infants